BioNTech SE
BNTX
$93.66
$0.320.34%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 3.26B | 3.32B | 3.53B | 3.13B | 2.97B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 3.26B | 3.32B | 3.53B | 3.13B | 2.97B |
| Cost of Revenue | 694.51M | 700.76M | 607.84M | 631.14M | 608.79M |
| Gross Profit | 2.57B | 2.62B | 2.92B | 2.49B | 2.36B |
| SG&A Expenses | 756.27M | 710.12M | 597.28M | 589.12M | 631.01M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 1.02B | 979.77M | 812.70M | 384.06M | 695.21M |
| Total Operating Expenses | 4.93B | 4.77B | 4.46B | 3.99B | 4.37B |
| Operating Income | -1.67B | -1.45B | -928.57M | -867.01M | -1.41B |
| Income Before Tax | -1.34B | -1.16B | -575.80M | -430.21M | -840.49M |
| Income Tax Expenses | 92.95M | 103.34M | 57.46M | -48.29M | -27.86M |
| Earnings from Continuing Operations | -1.44K | -1.26K | -633.26 | -381.92 | -812.62 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1.44B | -1.26B | -633.26M | -381.92M | -812.62M |
| EBIT | -1.67B | -1.45B | -928.57M | -867.01M | -1.41B |
| EBITDA | -1.28B | -1.16B | -552.74M | -587.57M | -1.13B |
| EPS Basic | -5.82 | -5.23 | -2.63 | -1.58 | -3.38 |
| Normalized Basic EPS | -3.21 | -2.86 | -1.33 | -0.89 | -1.97 |
| EPS Diluted | -5.82 | -5.23 | -2.63 | -1.60 | -3.40 |
| Normalized Diluted EPS | -3.21 | -2.86 | -1.33 | -0.89 | -1.98 |
| Average Basic Shares Outstanding | 978.08M | 965.14M | 961.42M | 963.84M | 962.63M |
| Average Diluted Shares Outstanding | 978.08M | 965.14M | 961.42M | 966.82M | 965.61M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |